Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Sublingual Methadone for the Management of Cancer Breakthrough Pain

This study has been completed.
Sponsor:
Collaborator:
Calgary Health Region
Information provided by:
AHS Cancer Control Alberta
ClinicalTrials.gov Identifier:
NCT00125294
First received: July 29, 2005
Last updated: January 18, 2012
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2007
  Primary Completion Date: June 2006 (Final data collection date for primary outcome measure)